Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

enGene Holdings Q1 Net Loss Attributable To Common Shareholders $(10.7)M Or $(0.46) Per Share

Author: Benzinga Newsdesk | March 11, 2024 05:41pm

The company closed a $200 million oversubscribed private financing, expected to extend cash runway into 2027.

Posted In: ENGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist